nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—COMT—prostate cancer	0.387	1	CbGaD
Tolcapone—COMT—Conjugated Estrogens—prostate cancer	0.221	0.611	CbGbCtD
Tolcapone—CYP2C9—Bicalutamide—prostate cancer	0.0413	0.114	CbGbCtD
Tolcapone—CYP2C9—Nilutamide—prostate cancer	0.0413	0.114	CbGbCtD
Tolcapone—CYP2C9—Estrone—prostate cancer	0.0247	0.0685	CbGbCtD
Tolcapone—CYP2C9—Capecitabine—prostate cancer	0.0187	0.0519	CbGbCtD
Tolcapone—CYP2C9—Estradiol—prostate cancer	0.0142	0.0394	CbGbCtD
Tolcapone—Entacapone—COMT—prostate cancer	0.00174	0.409	CrCbGaD
Tolcapone—Niclosamide—STAT3—prostate cancer	0.00156	0.367	CrCbGaD
Tolcapone—CYP2C9—urine—prostate cancer	0.00145	0.247	CbGeAlD
Tolcapone—COMT—prostate gland—prostate cancer	0.000991	0.168	CbGeAlD
Tolcapone—COMT—seminal vesicle—prostate cancer	0.000839	0.142	CbGeAlD
Tolcapone—COMT—renal system—prostate cancer	0.000676	0.115	CbGeAlD
Tolcapone—COMT—urethra—prostate cancer	0.000664	0.113	CbGeAlD
Tolcapone—COMT—bone marrow—prostate cancer	0.000511	0.0868	CbGeAlD
Tolcapone—Tolmetin—CXCL8—prostate cancer	0.000457	0.108	CrCbGaD
Tolcapone—COMT—testis—prostate cancer	0.000437	0.0742	CbGeAlD
Tolcapone—Tolmetin—MPO—prostate cancer	0.000356	0.0839	CrCbGaD
Tolcapone—COMT—lymph node—prostate cancer	0.000317	0.0538	CbGeAlD
Tolcapone—Tolmetin—PTGS2—prostate cancer	0.000133	0.0314	CrCbGaD
Tolcapone—COMT—Metabolism—HSD17B3—prostate cancer	4.78e-05	0.000678	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	4.6e-05	0.000653	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	4.6e-05	0.000653	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PHGDH—prostate cancer	4.58e-05	0.00065	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UMPS—prostate cancer	4.58e-05	0.00065	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ARG2—prostate cancer	4.58e-05	0.00065	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GPX3—prostate cancer	4.56e-05	0.000647	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LDHB—prostate cancer	4.49e-05	0.000638	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP3A5—prostate cancer	4.41e-05	0.000626	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—HPGDS—prostate cancer	4.34e-05	0.000617	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2C19—prostate cancer	4.32e-05	0.000613	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2C19—prostate cancer	4.26e-05	0.000604	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PDHA1—prostate cancer	4.26e-05	0.000604	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UCP3—prostate cancer	4.26e-05	0.000604	CbGpPWpGaD
Tolcapone—COMT—Metabolism—TCN2—prostate cancer	4.26e-05	0.000604	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA3—prostate cancer	4.26e-05	0.000604	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—prostate cancer	4.21e-05	0.000598	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2A6—prostate cancer	4.16e-05	0.000591	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MDM2—prostate cancer	4.15e-05	0.000589	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—prostate cancer	4.06e-05	0.000577	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD3B1—prostate cancer	4.06e-05	0.000577	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC22A3—prostate cancer	4.06e-05	0.000577	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	4.02e-05	0.00057	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—AKR1C3—prostate cancer	3.99e-05	0.000567	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP17A1—prostate cancer	3.99e-05	0.000566	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP17A1—prostate cancer	3.93e-05	0.000558	CbGpPWpGaD
Tolcapone—COMT—Metabolism—TBXAS1—prostate cancer	3.89e-05	0.000553	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA4—prostate cancer	3.89e-05	0.000553	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	3.81e-05	0.000541	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	3.81e-05	0.000541	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	3.81e-05	0.000541	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—NCOA2—prostate cancer	3.8e-05	0.00054	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA2—prostate cancer	3.79e-05	0.000539	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCG5—prostate cancer	3.75e-05	0.000532	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SULT1A1—prostate cancer	3.75e-05	0.000532	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA1—prostate cancer	3.66e-05	0.00052	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	3.63e-05	0.000516	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NAT2—prostate cancer	3.62e-05	0.000514	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTO1—prostate cancer	3.62e-05	0.000514	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD3B2—prostate cancer	3.62e-05	0.000514	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2E1—prostate cancer	3.54e-05	0.000503	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2E1—prostate cancer	3.49e-05	0.000496	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLCB2—prostate cancer	3.47e-05	0.000493	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2C18—prostate cancer	3.47e-05	0.000493	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LRP2—prostate cancer	3.47e-05	0.000493	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP3A4—prostate cancer	3.41e-05	0.000485	CbGpPWpGaD
Tolcapone—COMT—Metabolism—P4HB—prostate cancer	3.4e-05	0.000483	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP3A4—prostate cancer	3.37e-05	0.000478	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP1B1—prostate cancer	3.36e-05	0.000477	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1B1—prostate cancer	3.31e-05	0.00047	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC22A1—prostate cancer	3.31e-05	0.00047	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GGT1—prostate cancer	3.25e-05	0.000462	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	3.24e-05	0.00046	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SULT2A1—prostate cancer	3.23e-05	0.000458	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—NCOA1—prostate cancer	3.2e-05	0.000455	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MED12—prostate cancer	3.17e-05	0.000451	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP19A1—prostate cancer	3.16e-05	0.000448	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GNG5—prostate cancer	3.15e-05	0.000447	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP19A1—prostate cancer	3.11e-05	0.000442	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—RXRA—prostate cancer	3.05e-05	0.000432	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	3.04e-05	0.000432	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOA3—prostate cancer	3.03e-05	0.000431	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	2.96e-05	0.00042	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—COMT—prostate cancer	2.93e-05	0.000417	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—prostate cancer	2.92e-05	0.000415	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—COMT—prostate cancer	2.89e-05	0.000411	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPGDS—prostate cancer	2.89e-05	0.000411	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	2.89e-05	0.00041	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—prostate cancer	2.88e-05	0.000409	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2C19—prostate cancer	2.87e-05	0.000408	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTT1—prostate cancer	2.81e-05	0.000398	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACHE—prostate cancer	2.81e-05	0.000398	CbGpPWpGaD
Tolcapone—Hypotension—Docetaxel—prostate cancer	2.8e-05	0.000164	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—prostate cancer	2.8e-05	0.000163	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—prostate cancer	2.79e-05	0.000163	CcSEcCtD
Tolcapone—Loss of consciousness—Prednisone—prostate cancer	2.79e-05	0.000163	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP2A6—prostate cancer	2.77e-05	0.000394	CbGpPWpGaD
Tolcapone—Epistaxis—Doxorubicin—prostate cancer	2.77e-05	0.000162	CcSEcCtD
Tolcapone—Anorexia—Capecitabine—prostate cancer	2.77e-05	0.000162	CcSEcCtD
Tolcapone—Nausea—Estradiol—prostate cancer	2.77e-05	0.000162	CcSEcCtD
Tolcapone—Vomiting—Mitoxantrone—prostate cancer	2.76e-05	0.000161	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—prostate cancer	2.76e-05	0.000161	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	2.75e-05	0.000391	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	2.75e-05	0.000391	CbGpPWpGaD
Tolcapone—Hypertension—Prednisone—prostate cancer	2.74e-05	0.00016	CcSEcCtD
Tolcapone—Rash—Mitoxantrone—prostate cancer	2.74e-05	0.00016	CcSEcCtD
Tolcapone—Dermatitis—Mitoxantrone—prostate cancer	2.74e-05	0.00016	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.73e-05	0.00016	CcSEcCtD
Tolcapone—Headache—Mitoxantrone—prostate cancer	2.72e-05	0.000159	CcSEcCtD
Tolcapone—Hypotension—Capecitabine—prostate cancer	2.72e-05	0.000158	CcSEcCtD
Tolcapone—Arthralgia—Prednisone—prostate cancer	2.7e-05	0.000158	CcSEcCtD
Tolcapone—Myalgia—Prednisone—prostate cancer	2.7e-05	0.000158	CcSEcCtD
Tolcapone—COMT—Metabolism—AKR1C3—prostate cancer	2.7e-05	0.000383	CbGpPWpGaD
Tolcapone—Paraesthesia—Docetaxel—prostate cancer	2.7e-05	0.000157	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—prostate cancer	2.69e-05	0.000157	CcSEcCtD
Tolcapone—Anxiety—Prednisone—prostate cancer	2.69e-05	0.000157	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—prostate cancer	2.68e-05	0.000157	CcSEcCtD
Tolcapone—COMT—Metabolism—PRKACB—prostate cancer	2.68e-05	0.000381	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—prostate cancer	2.68e-05	0.000381	CbGpPWpGaD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.68e-05	0.000156	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—prostate cancer	2.68e-05	0.000156	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—prostate cancer	2.67e-05	0.000156	CcSEcCtD
Tolcapone—Discomfort—Prednisone—prostate cancer	2.67e-05	0.000156	CcSEcCtD
Tolcapone—Hypersensitivity—Etoposide—prostate cancer	2.66e-05	0.000155	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—prostate cancer	2.66e-05	0.000155	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP17A1—prostate cancer	2.66e-05	0.000377	CbGpPWpGaD
Tolcapone—Haemoglobin—Doxorubicin—prostate cancer	2.65e-05	0.000155	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.65e-05	0.000154	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—prostate cancer	2.65e-05	0.000376	CbGpPWpGaD
Tolcapone—Rhinitis—Doxorubicin—prostate cancer	2.64e-05	0.000154	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—prostate cancer	2.64e-05	0.000154	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—prostate cancer	2.64e-05	0.000154	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—prostate cancer	2.62e-05	0.000153	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—prostate cancer	2.62e-05	0.000153	CcSEcCtD
Tolcapone—Paraesthesia—Capecitabine—prostate cancer	2.61e-05	0.000152	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—prostate cancer	2.61e-05	0.000152	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—prostate cancer	2.6e-05	0.000152	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—prostate cancer	2.6e-05	0.000152	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Asthenia—Etoposide—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Dyspnoea—Capecitabine—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Oedema—Prednisone—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—prostate cancer	2.59e-05	0.000151	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—prostate cancer	2.58e-05	0.000151	CcSEcCtD
Tolcapone—Nausea—Mitoxantrone—prostate cancer	2.58e-05	0.00015	CcSEcCtD
Tolcapone—Infection—Prednisone—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Tolcapone—Constipation—Docetaxel—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Tolcapone—Pain—Docetaxel—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Tolcapone—Dyspepsia—Capecitabine—prostate cancer	2.56e-05	0.000149	CcSEcCtD
Tolcapone—Chills—Epirubicin—prostate cancer	2.56e-05	0.000149	CcSEcCtD
Tolcapone—Pruritus—Etoposide—prostate cancer	2.56e-05	0.000149	CcSEcCtD
Tolcapone—Shock—Prednisone—prostate cancer	2.55e-05	0.000149	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—prostate cancer	2.55e-05	0.000149	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—prostate cancer	2.54e-05	0.000361	CbGpPWpGaD
Tolcapone—Nervous system disorder—Prednisone—prostate cancer	2.54e-05	0.000148	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOA2—prostate cancer	2.53e-05	0.000359	CbGpPWpGaD
Tolcapone—Tachycardia—Prednisone—prostate cancer	2.53e-05	0.000147	CcSEcCtD
Tolcapone—Decreased appetite—Capecitabine—prostate cancer	2.53e-05	0.000147	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—prostate cancer	2.52e-05	0.000147	CcSEcCtD
Tolcapone—Skin disorder—Prednisone—prostate cancer	2.51e-05	0.000147	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HAO1—prostate cancer	2.51e-05	0.000356	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Capecitabine—prostate cancer	2.51e-05	0.000146	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—prostate cancer	2.51e-05	0.000356	CbGpPWpGaD
Tolcapone—Fatigue—Capecitabine—prostate cancer	2.51e-05	0.000146	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisone—prostate cancer	2.5e-05	0.000146	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—prostate cancer	2.5e-05	0.000146	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—prostate cancer	2.49e-05	0.000145	CcSEcCtD
Tolcapone—Pain—Capecitabine—prostate cancer	2.49e-05	0.000145	CcSEcCtD
Tolcapone—Constipation—Capecitabine—prostate cancer	2.49e-05	0.000145	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—prostate cancer	2.47e-05	0.000144	CcSEcCtD
Tolcapone—Diarrhoea—Etoposide—prostate cancer	2.47e-05	0.000144	CcSEcCtD
Tolcapone—Anorexia—Prednisone—prostate cancer	2.47e-05	0.000144	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—prostate cancer	2.46e-05	0.000143	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—prostate cancer	2.45e-05	0.000143	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—prostate cancer	2.44e-05	0.000143	CcSEcCtD
Tolcapone—Tension—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC5A5—prostate cancer	2.41e-05	0.000343	CbGpPWpGaD
Tolcapone—Nervousness—Epirubicin—prostate cancer	2.41e-05	0.000141	CcSEcCtD
Tolcapone—Feeling abnormal—Capecitabine—prostate cancer	2.39e-05	0.00014	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—prostate cancer	2.39e-05	0.00014	CcSEcCtD
Tolcapone—Dizziness—Etoposide—prostate cancer	2.39e-05	0.000139	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—prostate cancer	2.39e-05	0.000139	CcSEcCtD
Tolcapone—Gastrointestinal pain—Capecitabine—prostate cancer	2.38e-05	0.000139	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—prostate cancer	2.38e-05	0.000139	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—prostate cancer	2.37e-05	0.000138	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—prostate cancer	2.37e-05	0.000138	CcSEcCtD
Tolcapone—Chills—Doxorubicin—prostate cancer	2.37e-05	0.000138	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Prednisone—prostate cancer	2.36e-05	0.000138	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP2E1—prostate cancer	2.36e-05	0.000335	CbGpPWpGaD
Tolcapone—Arrhythmia—Doxorubicin—prostate cancer	2.36e-05	0.000137	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.34e-05	0.000332	CbGpPWpGaD
Tolcapone—Vision blurred—Epirubicin—prostate cancer	2.34e-05	0.000136	CcSEcCtD
Tolcapone—COMT—Metabolism—NQO1—prostate cancer	2.33e-05	0.000331	CbGpPWpGaD
Tolcapone—Alopecia—Doxorubicin—prostate cancer	2.33e-05	0.000136	CcSEcCtD
Tolcapone—Paraesthesia—Prednisone—prostate cancer	2.32e-05	0.000136	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—prostate cancer	2.31e-05	0.000135	CcSEcCtD
Tolcapone—Urticaria—Capecitabine—prostate cancer	2.31e-05	0.000135	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—prostate cancer	2.3e-05	0.000134	CcSEcCtD
Tolcapone—COMT—Metabolism—TH—prostate cancer	2.3e-05	0.000326	CbGpPWpGaD
Tolcapone—Body temperature increased—Capecitabine—prostate cancer	2.3e-05	0.000134	CcSEcCtD
Tolcapone—Abdominal pain—Capecitabine—prostate cancer	2.3e-05	0.000134	CcSEcCtD
Tolcapone—Vomiting—Etoposide—prostate cancer	2.3e-05	0.000134	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—prostate cancer	2.29e-05	0.000134	CcSEcCtD
Tolcapone—Agitation—Epirubicin—prostate cancer	2.28e-05	0.000133	CcSEcCtD
Tolcapone—Dyspepsia—Prednisone—prostate cancer	2.28e-05	0.000133	CcSEcCtD
Tolcapone—Rash—Etoposide—prostate cancer	2.28e-05	0.000133	CcSEcCtD
Tolcapone—Dermatitis—Etoposide—prostate cancer	2.28e-05	0.000133	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP3A4—prostate cancer	2.27e-05	0.000323	CbGpPWpGaD
Tolcapone—Headache—Etoposide—prostate cancer	2.26e-05	0.000132	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—prostate cancer	2.26e-05	0.000132	CcSEcCtD
Tolcapone—Tension—Doxorubicin—prostate cancer	2.25e-05	0.000131	CcSEcCtD
Tolcapone—Decreased appetite—Prednisone—prostate cancer	2.25e-05	0.000131	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—prostate cancer	2.25e-05	0.000131	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.24e-05	0.000319	CbGpPWpGaD
Tolcapone—Malaise—Epirubicin—prostate cancer	2.24e-05	0.000131	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP1B1—prostate cancer	2.24e-05	0.000317	CbGpPWpGaD
Tolcapone—Fatigue—Prednisone—prostate cancer	2.23e-05	0.00013	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—prostate cancer	2.23e-05	0.00013	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—prostate cancer	2.23e-05	0.00013	CcSEcCtD
Tolcapone—Syncope—Epirubicin—prostate cancer	2.22e-05	0.00013	CcSEcCtD
Tolcapone—Constipation—Prednisone—prostate cancer	2.21e-05	0.000129	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—prostate cancer	2.21e-05	0.000129	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—prostate cancer	2.21e-05	0.000129	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—prostate cancer	2.19e-05	0.000128	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—prostate cancer	2.18e-05	0.000127	CcSEcCtD
Tolcapone—COMT—Metabolism—GGT1—prostate cancer	2.17e-05	0.000307	CbGpPWpGaD
Tolcapone—Cough—Epirubicin—prostate cancer	2.16e-05	0.000126	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—prostate cancer	2.16e-05	0.000126	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.16e-05	0.000307	CbGpPWpGaD
Tolcapone—Asthenia—Docetaxel—prostate cancer	2.15e-05	0.000126	CcSEcCtD
Tolcapone—Nausea—Etoposide—prostate cancer	2.15e-05	0.000125	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—prostate cancer	2.14e-05	0.000125	CcSEcCtD
Tolcapone—Hypersensitivity—Capecitabine—prostate cancer	2.14e-05	0.000125	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisone—prostate cancer	2.13e-05	0.000124	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOA1—prostate cancer	2.13e-05	0.000303	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Doxorubicin—prostate cancer	2.13e-05	0.000124	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—prostate cancer	2.12e-05	0.000124	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—prostate cancer	2.12e-05	0.000124	CcSEcCtD
Tolcapone—Gastrointestinal pain—Prednisone—prostate cancer	2.12e-05	0.000124	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—prostate cancer	2.1e-05	0.000123	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP19A1—prostate cancer	2.1e-05	0.000299	CbGpPWpGaD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.1e-05	0.000122	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—prostate cancer	2.09e-05	0.000122	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.09e-05	0.000296	CbGpPWpGaD
Tolcapone—Asthenia—Capecitabine—prostate cancer	2.09e-05	0.000122	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—prostate cancer	2.07e-05	0.000121	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—prostate cancer	2.07e-05	0.000121	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—prostate cancer	2.06e-05	0.00012	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—prostate cancer	2.06e-05	0.00012	CcSEcCtD
Tolcapone—Urticaria—Prednisone—prostate cancer	2.06e-05	0.00012	CcSEcCtD
Tolcapone—Pruritus—Capecitabine—prostate cancer	2.06e-05	0.00012	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—prostate cancer	2.05e-05	0.00012	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—TST—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CSAD—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PSAT1—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CBR1—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADI1—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GRHL1—prostate cancer	2.05e-05	0.000291	CbGpPWpGaD
Tolcapone—Abdominal pain—Prednisone—prostate cancer	2.05e-05	0.000119	CcSEcCtD
Tolcapone—Body temperature increased—Prednisone—prostate cancer	2.05e-05	0.000119	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—prostate cancer	2.04e-05	0.000119	CcSEcCtD
Tolcapone—COMT—Metabolism—RXRA—prostate cancer	2.03e-05	0.000288	CbGpPWpGaD
Tolcapone—Palpitations—Doxorubicin—prostate cancer	2.03e-05	0.000118	CcSEcCtD
Tolcapone—Oedema—Epirubicin—prostate cancer	2.02e-05	0.000118	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—prostate cancer	2.02e-05	0.000118	CcSEcCtD
Tolcapone—Infection—Epirubicin—prostate cancer	2.01e-05	0.000117	CcSEcCtD
Tolcapone—Cough—Doxorubicin—prostate cancer	2e-05	0.000117	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2e-05	0.000284	CbGpPWpGaD
Tolcapone—Shock—Epirubicin—prostate cancer	1.99e-05	0.000116	CcSEcCtD
Tolcapone—Diarrhoea—Capecitabine—prostate cancer	1.99e-05	0.000116	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—prostate cancer	1.99e-05	0.000116	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—prostate cancer	1.98e-05	0.000116	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—prostate cancer	1.98e-05	0.000116	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—prostate cancer	1.98e-05	0.000116	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—prostate cancer	1.98e-05	0.000115	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—prostate cancer	1.97e-05	0.000115	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.96e-05	0.000279	CbGpPWpGaD
Tolcapone—Hyperhidrosis—Epirubicin—prostate cancer	1.96e-05	0.000114	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—prostate cancer	1.95e-05	0.000114	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—prostate cancer	1.95e-05	0.000114	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—prostate cancer	1.95e-05	0.000114	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—prostate cancer	1.95e-05	0.000114	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTP1—prostate cancer	1.94e-05	0.000276	CbGpPWpGaD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.94e-05	0.000113	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—prostate cancer	1.93e-05	0.000113	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—prostate cancer	1.93e-05	0.000113	CcSEcCtD
Tolcapone—Dizziness—Capecitabine—prostate cancer	1.92e-05	0.000112	CcSEcCtD
Tolcapone—COMT—Metabolism—ITPR1—prostate cancer	1.91e-05	0.000272	CbGpPWpGaD
Tolcapone—Dry mouth—Doxorubicin—prostate cancer	1.91e-05	0.000112	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—prostate cancer	1.91e-05	0.000111	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisone—prostate cancer	1.91e-05	0.000111	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—UGT2B15—prostate cancer	1.9e-05	0.00027	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UGT2B17—prostate cancer	1.9e-05	0.00027	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CKMT2—prostate cancer	1.9e-05	0.00027	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GRHPR—prostate cancer	1.9e-05	0.00027	CbGpPWpGaD
Tolcapone—Rash—Docetaxel—prostate cancer	1.89e-05	0.00011	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—prostate cancer	1.89e-05	0.00011	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—prostate cancer	1.89e-05	0.00011	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—prostate cancer	1.89e-05	0.00011	CcSEcCtD
Tolcapone—Headache—Docetaxel—prostate cancer	1.88e-05	0.00011	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—prostate cancer	1.87e-05	0.000109	CcSEcCtD
Tolcapone—Infection—Doxorubicin—prostate cancer	1.86e-05	0.000109	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.86e-05	0.000264	CbGpPWpGaD
Tolcapone—Asthenia—Prednisone—prostate cancer	1.86e-05	0.000108	CcSEcCtD
Tolcapone—Vomiting—Capecitabine—prostate cancer	1.85e-05	0.000108	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.84e-05	0.000108	CcSEcCtD
Tolcapone—Shock—Doxorubicin—prostate cancer	1.84e-05	0.000108	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—prostate cancer	1.84e-05	0.000107	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—prostate cancer	1.83e-05	0.000107	CcSEcCtD
Tolcapone—Rash—Capecitabine—prostate cancer	1.83e-05	0.000107	CcSEcCtD
Tolcapone—Pruritus—Prednisone—prostate cancer	1.83e-05	0.000107	CcSEcCtD
Tolcapone—Dermatitis—Capecitabine—prostate cancer	1.83e-05	0.000107	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.83e-05	0.00026	CbGpPWpGaD
Tolcapone—Tachycardia—Doxorubicin—prostate cancer	1.83e-05	0.000107	CcSEcCtD
Tolcapone—Headache—Capecitabine—prostate cancer	1.82e-05	0.000106	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—prostate cancer	1.82e-05	0.000106	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—prostate cancer	1.82e-05	0.000106	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—prostate cancer	1.81e-05	0.000106	CcSEcCtD
Tolcapone—COMT—Metabolism—TYMS—prostate cancer	1.81e-05	0.000257	CbGpPWpGaD
Tolcapone—Dyspnoea—Epirubicin—prostate cancer	1.81e-05	0.000105	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—prostate cancer	1.8e-05	0.000105	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SULT2B1—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MBTPS1—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAGLU—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—RFK—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PGAM2—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM3—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AOX1—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—prostate cancer	1.79e-05	0.000254	CbGpPWpGaD
Tolcapone—Anorexia—Doxorubicin—prostate cancer	1.79e-05	0.000104	CcSEcCtD
Tolcapone—Nausea—Docetaxel—prostate cancer	1.78e-05	0.000104	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—prostate cancer	1.78e-05	0.000104	CcSEcCtD
Tolcapone—Diarrhoea—Prednisone—prostate cancer	1.77e-05	0.000103	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—prostate cancer	1.76e-05	0.000103	CcSEcCtD
Tolcapone—COMT—Metabolism—LPL—prostate cancer	1.75e-05	0.000249	CbGpPWpGaD
Tolcapone—Hypotension—Doxorubicin—prostate cancer	1.75e-05	0.000102	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.75e-05	0.000248	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Epirubicin—prostate cancer	1.75e-05	0.000102	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—prostate cancer	1.75e-05	0.000102	CcSEcCtD
Tolcapone—Pain—Epirubicin—prostate cancer	1.73e-05	0.000101	CcSEcCtD
Tolcapone—Constipation—Epirubicin—prostate cancer	1.73e-05	0.000101	CcSEcCtD
Tolcapone—Nausea—Capecitabine—prostate cancer	1.73e-05	0.000101	CcSEcCtD
Tolcapone—Dizziness—Prednisone—prostate cancer	1.71e-05	9.99e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.71e-05	9.96e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—AMACR—prostate cancer	1.7e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP3A43—prostate cancer	1.7e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—DEGS1—prostate cancer	1.7e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAT1—prostate cancer	1.7e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SRD5A2—prostate cancer	1.7e-05	0.000241	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—prostate cancer	1.69e-05	0.000241	CbGpPWpGaD
Tolcapone—Paraesthesia—Doxorubicin—prostate cancer	1.68e-05	9.81e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—ERCC2—prostate cancer	1.68e-05	0.000239	CbGpPWpGaD
Tolcapone—Dyspnoea—Doxorubicin—prostate cancer	1.67e-05	9.74e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—prostate cancer	1.67e-05	9.73e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.67e-05	0.000237	CbGpPWpGaD
Tolcapone—Somnolence—Doxorubicin—prostate cancer	1.67e-05	9.72e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.66e-05	0.000235	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Epirubicin—prostate cancer	1.66e-05	9.66e-05	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—prostate cancer	1.65e-05	9.62e-05	CcSEcCtD
Tolcapone—Vomiting—Prednisone—prostate cancer	1.65e-05	9.6e-05	CcSEcCtD
Tolcapone—Rash—Prednisone—prostate cancer	1.63e-05	9.52e-05	CcSEcCtD
Tolcapone—Dermatitis—Prednisone—prostate cancer	1.63e-05	9.51e-05	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—prostate cancer	1.63e-05	9.5e-05	CcSEcCtD
Tolcapone—Headache—Prednisone—prostate cancer	1.62e-05	9.46e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HSD17B1—prostate cancer	1.62e-05	0.00023	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.62e-05	0.00023	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.62e-05	9.44e-05	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—prostate cancer	1.62e-05	9.42e-05	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—prostate cancer	1.61e-05	9.38e-05	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—prostate cancer	1.6e-05	9.35e-05	CcSEcCtD
Tolcapone—Pain—Doxorubicin—prostate cancer	1.6e-05	9.35e-05	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—prostate cancer	1.6e-05	9.34e-05	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—prostate cancer	1.6e-05	9.34e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—MTHFR—prostate cancer	1.58e-05	0.000224	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.56e-05	0.000221	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARA—prostate cancer	1.55e-05	0.00022	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.55e-05	0.00022	CbGpPWpGaD
Tolcapone—Feeling abnormal—Doxorubicin—prostate cancer	1.54e-05	9.01e-05	CcSEcCtD
Tolcapone—Nausea—Prednisone—prostate cancer	1.54e-05	8.97e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.53e-05	8.94e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.53e-05	0.000217	CbGpPWpGaD
Tolcapone—Hypersensitivity—Epirubicin—prostate cancer	1.49e-05	8.7e-05	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—prostate cancer	1.49e-05	8.68e-05	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—prostate cancer	1.48e-05	8.64e-05	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—prostate cancer	1.48e-05	8.64e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.46e-05	0.000207	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CAV1—prostate cancer	1.46e-05	0.000207	CbGpPWpGaD
Tolcapone—Asthenia—Epirubicin—prostate cancer	1.45e-05	8.48e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HPGD—prostate cancer	1.44e-05	0.000205	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—B4GALT4—prostate cancer	1.44e-05	0.000205	CbGpPWpGaD
Tolcapone—Pruritus—Epirubicin—prostate cancer	1.43e-05	8.36e-05	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—prostate cancer	1.39e-05	8.08e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—prostate cancer	1.38e-05	8.05e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—TNFRSF21—prostate cancer	1.36e-05	0.000193	CbGpPWpGaD
Tolcapone—Asthenia—Doxorubicin—prostate cancer	1.34e-05	7.84e-05	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—prostate cancer	1.34e-05	7.81e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CG—prostate cancer	1.33e-05	0.000188	CbGpPWpGaD
Tolcapone—Pruritus—Doxorubicin—prostate cancer	1.33e-05	7.73e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—MTAP—prostate cancer	1.32e-05	0.000187	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP7B1—prostate cancer	1.32e-05	0.000187	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.29e-05	0.000183	CbGpPWpGaD
Tolcapone—Vomiting—Epirubicin—prostate cancer	1.29e-05	7.51e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SULT1E1—prostate cancer	1.29e-05	0.000182	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SRD5A1—prostate cancer	1.29e-05	0.000182	CbGpPWpGaD
Tolcapone—Diarrhoea—Doxorubicin—prostate cancer	1.28e-05	7.48e-05	CcSEcCtD
Tolcapone—Rash—Epirubicin—prostate cancer	1.28e-05	7.45e-05	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—prostate cancer	1.28e-05	7.44e-05	CcSEcCtD
Tolcapone—Headache—Epirubicin—prostate cancer	1.27e-05	7.4e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—INS—prostate cancer	1.26e-05	0.000178	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.25e-05	0.000177	CbGpPWpGaD
Tolcapone—Dizziness—Doxorubicin—prostate cancer	1.24e-05	7.23e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—CREBBP—prostate cancer	1.23e-05	0.000175	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.23e-05	0.000175	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACSL4—prostate cancer	1.23e-05	0.000174	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.23e-05	0.000174	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.21e-05	0.000172	CbGpPWpGaD
Tolcapone—Nausea—Epirubicin—prostate cancer	1.2e-05	7.02e-05	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—prostate cancer	1.19e-05	6.95e-05	CcSEcCtD
Tolcapone—Rash—Doxorubicin—prostate cancer	1.18e-05	6.89e-05	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—prostate cancer	1.18e-05	6.89e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PHGDH—prostate cancer	1.18e-05	0.000167	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UMPS—prostate cancer	1.18e-05	0.000167	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ARG2—prostate cancer	1.18e-05	0.000167	CbGpPWpGaD
Tolcapone—Headache—Doxorubicin—prostate cancer	1.17e-05	6.85e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.17e-05	0.000166	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CD—prostate cancer	1.17e-05	0.000166	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LDHB—prostate cancer	1.15e-05	0.000164	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.13e-05	0.000161	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—prostate cancer	1.11e-05	6.49e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—NOS3—prostate cancer	1.1e-05	0.000156	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UCP3—prostate cancer	1.09e-05	0.000155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TCN2—prostate cancer	1.09e-05	0.000155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA3—prostate cancer	1.09e-05	0.000155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PDHA1—prostate cancer	1.09e-05	0.000155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC22A3—prostate cancer	1.04e-05	0.000148	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD3B1—prostate cancer	1.04e-05	0.000148	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CB—prostate cancer	1.02e-05	0.000144	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.01e-05	0.000144	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—prostate cancer	1.01e-05	0.000143	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA4—prostate cancer	9.99e-06	0.000142	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TBXAS1—prostate cancer	9.99e-06	0.000142	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.77e-06	0.000139	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA2—prostate cancer	9.74e-06	0.000138	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SULT1A1—prostate cancer	9.62e-06	0.000137	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCG5—prostate cancer	9.62e-06	0.000137	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA1—prostate cancer	9.4e-06	0.000133	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTO1—prostate cancer	9.29e-06	0.000132	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD3B2—prostate cancer	9.29e-06	0.000132	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAT2—prostate cancer	9.29e-06	0.000132	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.93e-06	0.000127	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLCB2—prostate cancer	8.91e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2C18—prostate cancer	8.91e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LRP2—prostate cancer	8.91e-06	0.000126	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—prostate cancer	8.79e-06	0.000125	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—P4HB—prostate cancer	8.74e-06	0.000124	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC22A1—prostate cancer	8.5e-06	0.000121	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.4e-06	0.000119	CbGpPWpGaD
Tolcapone—COMT—Metabolism—EP300—prostate cancer	8.38e-06	0.000119	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SULT2A1—prostate cancer	8.28e-06	0.000118	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MED12—prostate cancer	8.15e-06	0.000116	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GNG5—prostate cancer	8.08e-06	0.000115	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA3—prostate cancer	7.79e-06	0.000111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.65e-06	0.000109	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HPGDS—prostate cancer	7.43e-06	0.000105	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2C19—prostate cancer	7.38e-06	0.000105	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—prostate cancer	7.2e-06	0.000102	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACHE—prostate cancer	7.2e-06	0.000102	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2A6—prostate cancer	7.12e-06	0.000101	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.09e-06	0.000101	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKR1C3—prostate cancer	6.93e-06	9.84e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PRKACB—prostate cancer	6.89e-06	9.79e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP17A1—prostate cancer	6.82e-06	9.68e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.73e-06	9.55e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA2—prostate cancer	6.5e-06	9.23e-05	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—prostate cancer	6.2e-06	8.8e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A5—prostate cancer	6.2e-06	8.8e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2E1—prostate cancer	6.05e-06	8.6e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NQO1—prostate cancer	5.99e-06	8.5e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TH—prostate cancer	5.9e-06	8.38e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.86e-06	8.33e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.84e-06	8.29e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.81e-06	8.25e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.74e-06	8.15e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GGT1—prostate cancer	5.56e-06	7.89e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA1—prostate cancer	5.48e-06	7.78e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP19A1—prostate cancer	5.4e-06	7.66e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—RXRA—prostate cancer	5.21e-06	7.4e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.07e-06	7.19e-05	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—prostate cancer	5.06e-06	7.19e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—COMT—prostate cancer	5.02e-06	7.12e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—prostate cancer	4.99e-06	7.09e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ITPR1—prostate cancer	4.91e-06	6.98e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.83e-06	6.86e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TYMS—prostate cancer	4.64e-06	6.59e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—prostate cancer	4.59e-06	6.52e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LPL—prostate cancer	4.5e-06	6.4e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.35e-06	6.18e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ERCC2—prostate cancer	4.31e-06	6.13e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—prostate cancer	4.06e-06	5.76e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARA—prostate cancer	3.98e-06	5.65e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAV1—prostate cancer	3.74e-06	5.31e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.57e-06	5.08e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.41e-06	4.84e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—INS—prostate cancer	3.23e-06	4.58e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CREBBP—prostate cancer	3.16e-06	4.49e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—prostate cancer	3e-06	4.25e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NOS3—prostate cancer	2.83e-06	4.02e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.61e-06	3.71e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—prostate cancer	2.59e-06	3.67e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—prostate cancer	2.26e-06	3.2e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—EP300—prostate cancer	2.15e-06	3.06e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.59e-06	2.26e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—prostate cancer	1.3e-06	1.85e-05	CbGpPWpGaD
